Search

everythinglearnresearchcommunity

for

Search:↓

Blocking androgen receptors early in life increases estrogen levels and reduces sexual motivation in male rats.

RXRa is crucial for Th2 immune cell development and may link nutrition to immune health.

New compounds show promise for treating benign prostate hyperplasia with fewer side effects.

LPA3 signaling in the uterus is crucial for placental formation and fetal development.

Researchers developed new compounds that target the androgen receptor effectively with fewer side effects.

Breathing in newborn rats is affected differently by hormones based on their sex.

Parthenolide promotes hair growth in mice and may influence pathways related to male pattern baldness.

New treatments for cancer and skin disorders show promise in disrupting harmful cell interactions and promoting hair growth.

Early hormones shape sex-specific differences in rat glands.

TNFα, IFNγ, and Substance P significantly affect prolactin levels in human skin, suggesting new treatments for skin and hair conditions.

A new topical treatment for hair loss shows strong hair growth effects with low toxicity.

A protein called CBP is found in prostate cancer and can increase the effectiveness of certain prostate cancer treatments.

Glucocorticoids reduce fat production in liver cells, while androgens increase it in females; manipulating certain enzymes can influence these effects.

New LPA receptors (LPA4, LPA5, LPA6) have diverse roles in the body.

DHT affects bone growth by altering gene activity in osteoblasts, potentially complicating steroid use.

Certain peptides can prevent hair loss in young rats caused by a cancer drug.

Low doses of BPA can increase prostate growth and change hormone levels in adult rats.

SARMs work differently in tissues due to unique interactions and structures.

Early androgen exposure affects hormone receptor expression in adult female rats' brains, but not in males.

RANK is a key target in breast cancer treatment due to its role in tumor growth and bone metastasis.

The research found how GPCR Class A Rhodopsin receptors are related and suggested possible substances they interact with.

Progesterone and its byproducts control a specific receptor in the brain independently of progesterone receptors, affecting conditions related to the menstrual cycle.

The study found that androgen receptors in skin cells mainly affect the focal adhesion pathway and control the caveolin-1 gene, with implications for new treatments for related diseases.

Prolactin affects when mice shed and grow hair.

Prostate cells have proteins that bind to specific hormones, which can increase protein production when activated by these hormones.

Formyl-peptide receptor agonists could be new anti-inflammatory drugs.

RXR-alpha is strongly expressed in both normal and psoriatic skin and may help in skin cell differentiation and hair growth.

Therapies targeting the androgen receptor are being developed to treat prostate cancer and improve bone and muscle health.

The document concludes that adenosine receptor agonists have potential for treating various conditions, but only a few are approved due to challenges like side effects and the need for selective activation.

AH-001 could be a safer and more effective treatment for hair loss.